A rare association of localized scleroderma type morphea, vitiligo, autoimmune hypothyroidism, pneumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis. Case report

Article English OPEN
Bonilla-Abadía, Fabio ; Muñoz-Buitrón, Evelyn ; Ochoa, Carlos D ; Carrascal, Edwin ; Cañas, Carlos A (2012)
  • Publisher: BioMed Central
  • Journal: BMC Research Notes, volume 5, pages 689-689 (eissn: 1756-0500)
  • Related identifiers: doi: 10.1186/1756-0500-5-689, pmc: PMC3532086
  • Subject: Economía | Enfermedades autoinmunes | Vasculitis | Sistema nervioso central | Morphea | Case Report | Enfermedades sistémicas | Multiple autoimmune syndrome | Biochemistry, Genetics and Molecular Biology(all) | Economics | Localized scleroderma | Econometría | Econometrics models | Medicine(all) | Central nervous system vasculitis

Background The localized scleroderma (LS) known as morphea, presents a variety of clinical manifestations that can include systemic involvement. Current classification schemes divide morphea into categories based solely on cutaneous morphology, without reference to systemic disease or autoimmune phenomena. This classification is likely incomplete. Autoimmune phenomena such as vitiligo and Hashimoto thyroiditis associated with LS have been reported in some cases suggesting an autoimmune basis. To our knowledge this is the first case of a morphea forming part of a multiple autoimmune syndrome (MAS) and presenting simultaneously with autoimmune thrombocytopenic purpura and central nervous system vasculitis. Case presentation We report an uncommon case of a white 53 year old female patient with LS as part of a multiple autoimmune syndrome associated with pneumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis presenting a favorable response with thrombopoietin receptor agonists, pulses of methylprednisolone and cyclophosphamide. Conclusion Is likely that LS have an autoimmune origin and in this case becomes part of MAS, which consist on the presence of three or more well-defined autoimmune diseases in a single patient.
  • References (18)
    18 references, page 1 of 2

    1. Laxer RM, Zulian F: Localized scleroderma. Curr Opin Rheumatol 2006, 18:606-613.

    2. Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT: Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol 2009, 145:545-550.

    3. Dervis E, Acbay O, Barut G, Karaoglu A, Ersoy L: Association of vitiligo, morphea, and Hashimoto's thyroiditis. Int J Dermatol 2004, 43:236-237.

    4. Bonifati C, Impara G, Morrone A, Pietrangeli A, Carducci M: Simultaneous occurrence of linear scleroderma and homolateral segmental vitíligo. J Eur Acad Dermatol Venereol 2006, 20:63-65.

    5. Neucks SH, Moore TL, Lichtenstein JR, Baldassare AR, Weiss TD, Zuckner J: Localized scleroderma and idiopathic thrombocytopenia. J Rheumatol 1980, 7:741-744.

    6. Rondón P, Aguilar A, Gallego M: Thrombopenia associated to localized scleroderma. An Med Interna 2001, 18:88-89.

    7. Harrington CI, Dunsmore IR: An investigation into the incidence of autoimmune disorders in patients with localized morphoea. Br J Dermatol 1989, 120:645-648.

    8. Soylu S, Gül U, Gönül M, Kiliç A, Cakmak SK, Demiriz M: An uncommon presentation of the co-existence of morphea and vitiligo in a patient with chronic hepatitis B virus infection: is there a possible association with autoimmunity? Am J Clin Dermatol 2009, 10:336-338.

    9. Takehara K, Sato S: Localized scleroderma is an autoimmune disorder. Rheumatology (Oxford) 2005, 44:274-279.

    10. Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A, et al: Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol 2010, 162(5):1056-1063.

  • Related Research Results (1)
  • Metrics
    No metrics available